Call for Abstracts

Abstracts in English

Submissions for core sessions and general presentations must be submitted online from the JGES website.
Please click on "New submission" below.

Submission period

Open: 12:00pm, Wednesday, September 19, 2018 (Japan Time)
Close: 5:00pm, Monday, November 12, 2018 (Japan Time) 5:00pm, Monday, November 26, 2018 (Japan Time)


1.Notification on the Abstract submission for 97JGES
*Please read carefully the following notifications before your abstract submission.

2. Same theme from same affiliation
Only one abstract from the same affiliation can be submitted to each session. However, the presenting author can be listed as a co-author in abstracts from the other affiliations.

3. Similar abstracts
Abstracts considered to be the same will be discussed by the reviewers and program committee. Please note that when judged to be identical, both abstracts will be rejected.

4. Withdrawal and absence
Please keep in your mind any author who withdraws the abstract after receving acceptance notification or is absent without notice to 97JGES on the day of presentation shall be penalized according to the rules of the concerned society.

5. [For domestic presenters only] Regarding the review by ethics committee.
For submission of abstracts to 97JGES, aside from presentations that do not require the ethical review, the abstract be approved by the ethics committee in affiliated university hospitals, academic societies or medical association before your submission
A checklist regarding the ethics review is provided on the submission page. The checklist helps applicants to recognize the ethics policies for which compliance is obligatory. In the case that the abstract reviewers object to the declaration, applicants will be asked for reconfirmation, and if there is no response from the applicant, the abstract may be rejected.
Please confirm here to find the category to which your abstract applies.

>>Here to find the category to which your abstract applies

6. Please be sure to check COI (Conflict of Interest) before you submit the abstract.


1. The abstract should be unpublished at the Annual Meeting of the Japan Gastroenterological Endoscopy Society (JGES) and the other scientific meetings.
Notice: The accepted abstracts for international session will be published in Digestive Endoscopy.

2. Only one abstract from the same affiliation can be submitted to each session. However, the presenting author can be listed as a co-author in abstracts from the other affiliations.

3. Abstracts considered to be the same will be discussed by the reviewers and program committee. Please note that when the abstracts are judged to be identical, both of them will be rejected.

4. The conference proceedings will be available through an app for smart phones and tablets. Please understand that the accepted abstracts will be electronically published.

5. The copyright for your abstract shall be transferred to the Japan Gastroenterological Endoscopy Society. If you disagree with it, your abstract shall not be accepted for presentation nor be included in the Proceedings.

●Categories and Presentation type
○Content Category 1 *Please choose one.

01 Oral and oropharyngeal 06 Large intestine
02 Esophageal 07 Biliary
03 Gastric 08 Pancreatic
04 Duodenal 09 Hepatic
05 Small intestine 10 Other
○Content Category 2 *Please choose two preferences.

1 Neoplasm 18 Endoscopic hemostasis
2 Functional disease 19 Varicosis treatment
3 Infectious disease(Including H. pylori 20 Emergency endoscopy
4 Inflammatory disease 21 Ultrathin endoscopes (including perinasal endoscopy)
5 Image management systems 22 Capsule endoscopy
6 Image analysis and processing 23 Intestinal endoscopy
7 Endoscope cleaning and disinfection 24 Gastrostomy
8 Pretreatment and perioperative management 25 Stents and dilation
9 Sedation 26 Laser treatment and PDT
10 Education and training 27 Diagnostic laparoscopy
11 Risk management (including elderly patients) 28 Laparoscopic surgery
12 Magnification, high-magnification, and image-enhancing endoscopy 29 Foreign body removal
13 ESD and EMR 30 Obesity treatment
14 New minimally invasive endoscopy 31 Notes
15 EUS 32 POEM
16 EUS and FNA technique 33 Other
17 ERCP and ERCP-related technique    
●Theme sessions

Theme sessions Symposium [English session, Public Submission]
S07_Diagnosis and treatment for SM cancer using "JNET" classification

Yutaka Saito, National Cancer Center Hospital
Shoichi Saito, The Cancer Institute Hospital of JFCR

It has been long time since therapeutic strategies for submucosal invasive colon cancer (SM cancer) started to be discussed. Recently, as ESD procedures have become more widespread, the object of a total biopsy has also been discussed that take into consideration for additional surgery based upon pathological findings after an en bloc endoscopic resection, which is, mainly in the lower rectal region.
The issue here concerns therapeutic strategies that conform to the colorectal cancer treatment guidelines. The risk factors for lymph node metastasis are for the most part concentrated into "histological type," "budding grade," and "vascular and lymphovascular invasion", and the rate of lymph node metastasis has been reported to be a very low at between approximately 2 and 3% in the case of differentiated adenocarcinoma deeper than 1000μm without any other risk factors. On the other hand, the deeper the invasion depth, the greater the frequency of vascular invasion, and, even if immune-staining is performed, diagnostic concordance for lymphovascular invasion is estimated low.
Many problems have not been solved including how to handle cases where the muscularis mucosae has been ruptured, and how to deal with PG-type or NPG-type, and the upper limits of the invasive depth have not been stipulated at depths greater than 1000μm.
This session will focus mainly on cases of long-term follow-up after therapeutic endoscopy (including cases of additional surgeries; using a median of three years or more as desirable) and cases of follow-up after surgical resection, with evidence-based reports including the recurrence rate (regional/distant metastases), and the lymph node metastasis rate. Multicenter study reports are also welcome.
Please state whether immune-histological staining was done or not. In addition, reports are also welcome about advanced approaches, including predicting future lymph node metastasis using artificial intelligence (AI). A pathologist will also have prepared some special remarks on the day of the panel discussion.

Theme sessions Panel Discussions [English session, Public Submission]
PD03. Current status and future perspectives of device-assisted endoscopy

Hironori Yamamoto, Jichi Medical University
Kazuo Ohtsuka, University Hospital of Medicine, Tokyo Medical and Dental University

Balloon-assisted endoscopy has established the position as a method that has surmounted the limits of conventional endoscopy. In terms of reachability, it has become the gold standard for small intestine examinations and used not only for endoscopic observations, but also for therapeutic endoscopy. In terms of stability, it has been used for procedures requiring the intestine to be held stably for a long period of time, such as ESD in the deep colon. In addition to double-balloon endoscopy, there is single-balloon endoscopy. There are multiple devices used that include longer and shorter scope lengths. Moreover, in Europe and the United States, studies are underway on spiral endoscopy. The indications of device-assisted endoscopy adaptations is widening.
However, due to procedure complexity, cost concerns and other factors, the use of device-assisted endoscopy is still not sufficiently widespread.
Collaboration with other modalities has also been sought. In this panel discussion, we would like to ask that the panelists focus on technical aspects and engage in a multi-faceted discussion from a variety of perspectives about the current status and future perspectives of device-assisted endoscopy.
Approaches for the biliary tract and pancreas in post-surgical modified intestinal tracts will be left for another forum.

Theme sessions Workshops [English session, Public Submission]
WS02. Progress in full-thickness excision surgery in the gastrointestinal tract

Kazuki Sumiyama, Jikei University School of Medicine
Nobutsugu Abe, Kyorin University School of Medicine

The indications for endoscopic treatments of GI cancer have been greatly expanded by the recent developments of ESD. The wide spread use of ESD in daily clinical practice has made endoscopic resection the primary therapeutic option for early stage cancers regardless of the site of the GI tract. However, therapeutic targets of endoscopic resection had been confined to superficial tumors within the gut wall, even though endoscopists frequently encounter diseases raised from deeper layers such as submucosal tumors and achalasia. Perforation still remains one of the worst case scenarios for most of endoscopists. The development of techniques of endoscopic full-thickness resection (EFTR) including technologies to securely close the perforation site had been one of most long-lasting dreams for endoscopists. Recently, technological advancements in fields of laparoscopy-endoscopy collaboration, EUS-guided interventions, submucosal endoscopy, and suturing devices for flexible endoscopy enabled pilot trials of EFTR in clinical settings to be initiated at multiple locations. This workshop will update the current status of EFTR and relevant researches, and discuss future perspectives of the technology with panels and invited lecturers.

Theme Workshops [English session, Public Submission]
WS06. Current situation and new developments in interventional EUS

Mitsuhiro Kida, Kitasato University
Takao Itoi, Tokyo Medical University

In recent years, new diagnoses and treatments using EUS are tried out. In regard to EUS-FNA, effectiveness in not only simple tissue diagnosis but also Precision Medicine using FNA specimens as well as drug susceptibility tests has been reported. On the other hand, for drainage under the conventional EUS guide for peripancreatic liquid accumulation, bile ducts and gallbladders, devices such as dedicated plastic stents and Lumen-apposing metal stents have become commercially available, enabling safer and more secure techniques. Furthermore, new techniques such as gastrointestinal anastomosis, which departs from conventional drainage techniques, has appeared for the future. In this workshop, let us discuss the future of EUS treatment using new devices and techniques. Simple presentations of results of EUS-FNA will be omitted.

Presentation type

●Presentation type *Please choose one.
1. Apply for theme sessions: Withdraw the abstract if not accepted
2. Apply for theme sessions: Oral if not accepted
3. Apply for theme sessions: Poster if not accepted
4. Apply for theme sessions: Oral or Poster(Either)if not accepted
5. Oral preferred
6. Poster preferred
7. Oral or Poster (Either)

●Poster sessions
The size of the poster pin-up board is 90 cm in width by 160 cm in height. Please prepare your poster with the title of topics, name of presenters and affiliations in the side of 70 cm across by 20 cm high. The abstract numbers shall be prepared by the Secretariat.
On the day of the session, all presenters are essentially required to attend the session during above scheduled time.

Instruction for preparing abstract

1. Refer to the glossary of the Japan Gastroenterological Endoscopy Society (JGES) and apply suitable words and terms.

2. The title of the abstract should be no longer than 120 one-byte characters including spaces. (approx. 20 words)

3. The total number of the presenting author and co-author must be no more than 20 members.

4. The number of the institutions must not exceed 10.

5. Abstract body: There should be within 2170 one-byte characters including title, authors' names and affiliations and spaces. (In case of using pictures and/or graphs, the abstract body should be within 1410 one-byte characters including title, authors' names and affiliations and spaces.)

Abstract Submission No. and Password

Password for View/Update should be between 6 and 8 character long. This password is necessary for you to view or edit your abstract.

You may revise and modify your abstract at any time until the deadline for abstract submission. You will be requested to enter your Registration No. given at the time of registration and your registered password.

In order to prevent a third party from reading and misusing your information, the Secretariat of the 97th congress of JGES will not disclose any information on registration number and password. We highly recommend you to write down your Registration No. and Password. If you forget them, you have to submit your abstract once more.

Acceptance of submitted abstracts

Make sure to input the correct E-mail address, as the result of the review will be sent to the registered e-mail address.

How We Handle Personal Information

The 97th JGES entrusts the collecting, storing, and handling of the personal information provided to us.

The personal information that you provide through the online submission system, will be used for the following purposes only:
1) to answer your inquiries regarding the congress;
2) to send you the notification of review results; and
3) to post your names, affiliations, presentation titles and abstracts on the official website and publish the proceedings.

Abstract Submission

For security reasons, we recommend you not to use plaintext-based web communications for your abstract submissions.
*This abstract submission system works only on the following browsers: Internet Explorer, Firefox, Google Chrome and Safari (ver. 2.0.3 (471.9.2) or later). Please do not use other browsers for abstract submission.


97th JGES Acting Secretariat Office
c/o Convention Academia, Inc.
#4F Hongo-UC Building, 3-35-3 Hongo,
Bunkyo-ku, Tokyo 113-0033 JAPAN
TEL. +81-3-5805-5261
FAX. +81-3-3815-2028